Literature DB >> 8828120

Establishment of a rabbit model for bovine herpesvirus type 5 neurological acute infection.

G Meyer1, M Lemaire, J Lyaku, P P Pastoret, E Thiry.   

Abstract

This study was conducted to evaluate the suitability of the rabbit as a model for bovine, herpesvirus 5 (BHV-5) acute infection. In a preliminary experiment, a total of 24 one-month old New Zealand white rabbits were inoculated with BHV-5 or bovine herpesvirus 1 (BHV-1) by the intraconjunctival, intracerebral or intranasal routes. BHV-5 or BHV-1 inoculated in the conjunctiva induced virus proliferation in the eye mucosae and the nasal cavity of rabbits without meningo-encephalitis. On the other hand, only BHV-5 infection by intranasal or intracerebral routes produced a fatal meningo-encephalitis. The intranasal route was used in a further experiment for the establishment of a rabbit model for BHV-5 infection. A total of 45 rabbits were inoculated intranasally with BHV-5 or BHV-1. The results showed that intranasal inoculation of BHV-5 strain N569 in rabbits was followed by the development of a lethal meningo-encephalitis for 66% of rabbits while all BHV-1 infected rabbits remained healthy throughout this experiment (28 days). Analysis between the mortalities of rabbits infected with BHV-5 and BHV-1 were highly significant (p < 0.001). The presence of BHV-5 in the central nervous system (CNS) was confirmed by virus isolation (essentially the cerebrum, midbrain and pons) and by immunohistochemical staining of BHV-5 antigen (essentially in the neurons of the cerebrum) only in BHV-5 infected rabbits showing clinical signs of meningo-encephalitis. The findings obtained confirmed the suitability of a rabbit model for the establishment of BHV-5 neurological acute infection and also as a valuable tool for the comparative study of BHV-5 and BHV-1 neuropathogenicity.

Entities:  

Mesh:

Year:  1996        PMID: 8828120     DOI: 10.1016/0378-1135(96)00016-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Susceptibility of mice to bovine herpesvirus type 5 infection in the central nervous system.

Authors:  L P Mesquita; R C Costa; M M Fusuma; F R P Bruhn; E Mori; E M Pituco; C M C Mori; R Weiblen; P C Maiorka
Journal:  Vet Res Commun       Date:  2017-09-23       Impact factor: 2.459

2.  Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brain.

Authors:  Evgeni Gabev; Kurt Tobler; Carlos Abril; Monika Hilbe; Claudia Senn; Marco Franchini; Gabriella Campadelli-Fiume; Cornel Fraefel; Mathias Ackermann
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

3.  NTPDase and 5'-nucleotidase activities in synaptosomes of rabbits experimentally infected with BoHV-5.

Authors:  Cássia B da Silva; Francine C Paim; Patricia Wolkmer; Fátima H Abdalla; Fabiano B Carvalho; Heloísa H Palma; Camila B E Mello; Eduardo F Flores; Cinthia M Andrade; Sonia T A Lopes
Journal:  J Neurovirol       Date:  2015-05-30       Impact factor: 2.643

4.  Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient mice.

Authors:  Carlos Abril; Monika Engels; Anne Liman; Monika Hilbe; Sarah Albini; Marco Franchini; Mark Suter; Mathias Ackermann
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Bovine herpesvirus 5 induces an overproduction of nitric oxide in the brain of rabbits that correlates with virus dissemination and precedes the development of neurological signs.

Authors:  R Dezengrini; M Weiss; F D Torres; M S Oliveira; F Furian; C F Mello; R Weiblen; E F Flores
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

6.  Cloning of Bovine herpesvirus type 1 and type 5 as infectious bacterial artifical chromosomes.

Authors:  Evgeni Gabev; Cornel Fraefel; Mathias Ackermann; Kurt Tobler
Journal:  BMC Res Notes       Date:  2009-10-14

Review 7.  Review of companion animal viral diseases and immunoprophylaxis.

Authors:  J R Patel; J G M Heldens
Journal:  Vaccine       Date:  2008-11-27       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.